AstraZeneca Targets Korean Co. Over Nexium Patents
U.K.-based AstraZeneca AB has sued Hanmi Pharmaceutical Co., accusing the South Korean company of infringing two patents by attempting to sell a copycat version of its acid reflux medication Nexium....To view the full article, register now.
Already a subscriber? Click here to view full article